Jamieson Wellness (TSE:JWEL) Sets New 52-Week High - Still a Buy?

Key Points

• Jamieson Wellness shares reached a new 52-week high of C$45.75 and were trading near C$45.60, with the stock’s market capitalization at approximately C$1.89 billion.
• Analyst sentiment has weakened, with several firms downgrading the stock to “Hold” or “Sector Perform.” The consensus rating is “Hold,” with an average price target of C$46.43.
• The company reported quarterly EPS of C$0.46 on revenue of C$233.84 million and pays a quarterly dividend of C$0.23 per share, equivalent to a 2.0% annualized yield and a 50.27% payout ratio.

Jamieson Wellness Inc. (TSE:JWEL - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Friday . The company traded as high as C$45.75 and last traded at C$45.60, with a volume of 125613 shares traded. The stock had previously closed at C$45.66.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on JWEL. Canadian Imperial Bank of Commerce lowered Jamieson Wellness from an "outperformer" rating to a "tender" rating and lifted their price objective for the stock from C$44.00 to C$45.75 in a research note on Friday, August 7th. Canaccord Genuity Group lowered Jamieson Wellness from a "buy" rating to a "hold" rating and boosted their price target for the company from C$44.50 to C$45.75 in a research note on Monday. TD downgraded shares of Jamieson Wellness from a "buy" rating to a "hold" rating and raised their price objective for the stock from C$48.00 to C$49.00 in a report on Monday. Royal Bank Of Canada cut Jamieson Wellness from an "outperform" rating to a "sector perform" rating and lowered their price target for the company from C$46.00 to C$45.75 in a research report on Monday. Finally, Stifel Nicolaus lowered Jamieson Wellness from a "buy" rating to a "hold" rating and increased their price target for the stock from C$45.00 to C$45.75 in a research report on Friday, August 7th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of C$46.43.

Jamieson Wellness Price Performance

The stock has a market cap of C$1.89 billion, a price-to-earnings ratio of 24.93 and a beta of 1.48. The company has a debt-to-equity ratio of 93.69, a quick ratio of 1.08 and a current ratio of 3.41. The company has a 50-day simple moving average of C$40.48 and a two-hundred day simple moving average of C$37.04.

Jamieson Wellness (TSE:JWEL - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported C$0.46 EPS for the quarter. The business had revenue of C$233.84 million for the quarter. Jamieson Wellness had a net margin of 8.92% and a return on equity of 15.93%. As a group, equities research analysts forecast that Jamieson Wellness Inc. will post 2.1438892 EPS for the current year.

Jamieson Wellness Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 15th were issued a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Monday, June 1st. Jamieson Wellness's payout ratio is 50.27%.

About Jamieson Wellness

Jamieson Wellness Inc is engaged in the manufacturing, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Progressive, Precision, and Iron Vegan. Geographically, most of its revenue is derived from the domestic market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source